mRNA |
LY-2183240 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
5e-09 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
7e-09 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
8e-09 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
1e-08 |
mRNA |
SB-225002 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
1e-08 |
mRNA |
BI-2536 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
2e-08 |
mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-08 |
mRNA |
GMX-1778 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
2e-08 |
mRNA |
BRD1812 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
2e-08 |
mRNA |
BIX-01294 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
3e-08 |